您即将离开沛嘉医疗中文官网。
您刚才点击了进入另一网站的链接。如果继续,您可能会进入由第三方运行的网站。 我们不负责对非沛嘉医疗中文官网上的内容进行审核与管控,亦不会对您在非沛嘉医疗中文网上的任何商业交易或事物承担任何责任。您使用其他网站时,必须遵循该网站的使用条款及隐私声明。 其他网站上的部分产品和信息可能并未在您所在地区或国家获得批准。
取消
继续
Company News
Company News Brief News on Innovation
PEIJIA MEDICAL APPROVED AS JIANGSU PROVINCEPOSTDOCTORAL INNOVATION PRACTICE BASE
2024-12-19 10:54:10

In January 2025, the Jiangsu ProvincialDepartment of Human Resources and SocialSecurity released the "List of NewlyEstablished Jiangsu Province PostdoctoralInnovation Practice Bases for 2024." Amongthem, 42 units in Suzhou were successfullyapproved, continuing to lead the province innumber. In this selection, Peijia Medical wassuccessfully approved as a provincialpostdoctoral innovation practice base.

As an important platform for provincial postdoctoral research, theestablishment of the base holds significant importance for attractingand gathering postdoctoral talent, enhancing technological innovationcapabilities, and promoting the transformation of scientific researchachievements.


Top